Description

4-(4-Bromophenyl)-4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine is a high-purity, advanced pharmaceutical intermediate with a fused heterocyclic structure, offering a critical building block for complex molecular synthesis. Its value lies in its role as a versatile precursor for the development of active pharmaceutical ingredients (APIs) and other fine chemicals, where precise chemical architecture is paramount. This compound is essential for research and development chemists, process chemists, and manufacturers in the pharmaceutical, agrochemical, and life science industries seeking to innovate and scale new therapeutic agents.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the research and production of novel drug candidates, particularly those targeting central nervous system (CNS) disorders.
• Agrochemical Synthesis: Used in the development of advanced crop protection agents and pesticides requiring specific heterocyclic frameworks.
• Chemical Research & Development: Serves as a versatile scaffold in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization.
• Ligand and Catalyst Development: Potential utility in creating specialized ligands for metal catalysis or as a core structure in organocatalysts.
• Material Science Research: Investigated for the synthesis of organic electronic materials or specialty polymers with unique properties.

Basic Information

Item	Details
Product Name	4-(4-Bromophenyl)-4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine
CAS No.	7271-11-6
Molecular Formula	C12H12BrN3
Molecular Weight	278.15 g/mol
Synonyms	4-(4-Bromophenyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine; 4-(p-Bromophenyl)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine; 7271-11-6; 4-(4-Bromophenyl)-4,5,6,7-tetrahydroimidazo[4,5-c]pyridine; 4-(4-Bromophenyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine; 4-(4-Bromophenyl)-4,5,6,7-tetrahydroimidazo[4,5-c]pyridine; 4-(4-Bromophenyl)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine
EINECS	Contact for details

Quality Control

Our 4-(4-Bromophenyl)-4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the stringent requirements for pharmaceutical intermediate applications. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with each shipment and is available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated place at a controlled room temperature (typically 15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.